CIK 0001710155 · Ophthalmic Goods (SIC 3851) · Nasdaq · incorporated in DE · fiscal year ends 01/02
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 2.0 B | 1.6 B | ||
| Net income (USD) | -28.5 M | 36.3 M | 32.8 M | |
| Diluted EPS (USD/shares) | 0.37 | 0.52 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-08 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-09-09 | 4 | FORM 4 | 2026-09-08 |
| 2026-09-03 | 4 | FORM 4 | 2026-09-02 |
| 2026-08-21 | 4 | FORM 4 | 2026-08-19 |
| 2026-08-13 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-13 | 10-Q | 10-Q | 2026-07-04 |
| 2026-08-12 | 8-K | 8-K items 2.02,9.01 | 2026-08-12 |
| 2026-08-06 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-06 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-03 | 4 | FORM 4 | 2026-07-31 |
| 2026-07-31 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-09 | 4 | FORM 4 | 2026-07-08 |
| 2026-06-22 | 4 | FORM 4 | 2026-06-17 |
| 2026-06-22 | 4 | FORM 4 | 2026-06-17 |
| 2026-06-22 | 4 | FORM 4 | 2026-06-17 |
| 2026-06-22 | 4 | FORM 4 | 2026-06-17 |
| 2026-06-22 | 4 | FORM 4 | 2026-06-17 |
| 2026-06-22 | 4 | FORM 4 | 2026-06-17 |
| 2026-06-22 | 4 | FORM 4 | 2026-06-17 |
| 2026-06-22 | 4 | FORM 4 | 2026-06-17 |
| 2026-06-22 | 8-K | 8-K items 5.07,9.01 | 2026-06-17 |
| 2026-06-09 | 4 | FORM 4 | 2026-06-05 |
| 2026-06-03 | 8-K | 8-K items 7.01,9.01 | 2026-06-03 |
| 2026-05-14 | 10-Q | 10-Q | 2026-04-04 |
| 2026-05-13 | 8-K | 8-K items 2.02,9.01 | 2026-05-13 |
Forms on file (last 1,000): 4 359, 8-K 93, SC 13G/A 44, 3 41, 10-Q 27, SC 13G 15, 144 12, SCHEDULE 13G/A 11. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=EYE (0.002 USD), /gw/filings/filings?ticker=EYE&form=8-K, /gw/filings/facts?ticker=EYE&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange